ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,282,800 | +44.8% | 235,376 | +78.3% | 0.00% | – |
| Q2 2023 | $885,882 | -77.5% | 132,024 | -70.3% | 0.00% | – |
| Q1 2023 | $3,930,895 | +264.1% | 445,175 | +215.0% | 0.00% | – |
| Q4 2022 | $1,079,716 | -9.4% | 141,324 | -15.6% | 0.00% | – |
| Q3 2022 | $1,192,000 | -13.7% | 167,377 | -1.9% | 0.00% | – |
| Q2 2022 | $1,381,000 | -52.5% | 170,675 | -18.5% | 0.00% | – |
| Q1 2022 | $2,908,000 | -55.5% | 209,475 | -10.1% | 0.00% | -100.0% |
| Q4 2021 | $6,534,000 | +2.1% | 232,888 | +23.7% | 0.00% | 0.0% |
| Q3 2021 | $6,398,000 | -20.5% | 188,248 | -4.4% | 0.00% | 0.0% |
| Q2 2021 | $8,050,000 | +37.9% | 197,001 | +35.9% | 0.00% | 0.0% |
| Q1 2021 | $5,836,000 | -34.5% | 144,971 | -3.8% | 0.00% | 0.0% |
| Q4 2020 | $8,914,000 | +13.6% | 150,749 | -6.6% | 0.00% | 0.0% |
| Q3 2020 | $7,847,000 | -8.2% | 161,380 | -8.7% | 0.00% | 0.0% |
| Q2 2020 | $8,552,000 | +129.7% | 176,793 | +31.9% | 0.00% | 0.0% |
| Q1 2020 | $3,723,000 | -34.0% | 134,002 | -28.9% | 0.00% | 0.0% |
| Q4 2019 | $5,638,000 | +666.0% | 188,431 | +690.1% | 0.00% | – |
| Q3 2019 | $736,000 | – | 23,849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |